SELLAS Life Sciences Group, Inc.
SLS
$1.91
$0.09235.07%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Net Income | -13.56% | 13.72% | 5.22% | 4.85% | 21.91% |
Total Depreciation and Amortization | -- | -- | -- | -- | -- |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | -0.31% | 25.14% | 0.58% | 9.75% | -23.13% |
Change in Net Operating Assets | 64.72% | -317.18% | 22.94% | 54.69% | -48.37% |
Cash from Operations | 19.18% | -26.80% | 8.37% | 19.38% | 10.03% |
Capital Expenditure | -- | -- | -- | -- | -- |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -- | -- | -- | -- | -- |
Cash from Investing | -- | -- | -- | -- | -- |
Total Debt Issued | -- | -- | -- | -- | -- |
Total Debt Repaid | -- | -- | -- | -- | -- |
Issuance of Common Stock | -82.06% | 32,651.39% | -99.63% | 4,656.04% | -98.45% |
Repurchase of Common Stock | -- | -- | -- | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -- | -- | -- | -- | -- |
Cash from Financing | -82.06% | 294,662.50% | -99.96% | 4,656.04% | -98.45% |
Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | -121.36% | 303.09% | -160.12% | 228.23% | -158.34% |